Publications
View AllEfficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
In our trial, HZ/su was found to reduce the risks of herpes zoster and postherpetic neuralgia among adults 70 years of age or older. (Funded by GlaxoSmithKline Biologicals; ZOE-...
Institution Info
- Type
- facility
- Country
- AU
- Publications
- 2
- Citations
- 4,938
External Links
Identifiers
- ROR
- https://ror.org/04zj3ra44